anmelden
NASDAQ Composite Index
25.832,67
PKT
-207,36
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.08.12 | Henry Schein outperform | Barrington Research | |
| 07.08.12 | ImmunoGen neutral | JP Morgan Chase & Co. | |
| 06.08.12 | Alphabet A (ex Google) halten | Hamburger Sparkasse AG (Haspa) | |
| 06.08.12 | ImmunoGen buy | Jefferies & Company Inc. | |
| 06.08.12 | Logitech neutral | Sarasin Research | |
| 06.08.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 06.08.12 | Abbott Laboratories kaufen | Die Actien-Börse | |
| 06.08.12 | Intel kaufen | Die Actien-Börse | |
| 03.08.12 | Synaptics buy | Needham & Company, LLC | |
| 03.08.12 | ANSYS outperform | Robert W. Baird & Co. Incorporated | |
| 03.08.12 | Anglo American halten | Independent Research GmbH | |
| 03.08.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
| 03.08.12 | Apple outperform | RBC Capital Markets | |
| 02.08.12 | Comcast buy | UBS AG | |
| 02.08.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.08.12 | Amgen halten | Independent Research GmbH | |
| 02.08.12 | Microchip Technology buy | Nomura | |
| 02.08.12 | Vertex Pharmaceuticals buy | Banc of America Securities-Merrill Lynch | |
| 02.08.12 | Electronic Arts buy | Stifel, Nicolaus & Co., Inc. | |
| 02.08.12 | Ceva sector perform | RBC Capital Markets | |
| 02.08.12 | Take Two neutral | Piper Jaffray & Co. | |
| 02.08.12 | Electronic Arts neutral | Macquarie Research | |
| 01.08.12 | Anglo American neutral | Credit Suisse Group | |
| 01.08.12 | Microchip Technology buy | UBS AG | |
| 01.08.12 | Vertex Pharmaceuticals neutral | Piper Jaffray & Co. | |
| 01.08.12 | Apple outperform | Sanford C. Bernstein and Co., Inc. | |
| 01.08.12 | Anglo American neutral | Exane-BNP Paribas SA | |
| 01.08.12 | Apple overweight | Morgan Stanley | |
| 01.08.12 | Vertex Pharmaceuticals outperform | Credit Suisse Group | |
| 01.08.12 | Cirrus Logic buy | Stifel, Nicolaus & Co., Inc. | |
| 31.07.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 31.07.12 | Vertex Pharmaceuticals buy | UBS AG | |
| 31.07.12 | Cirrus Logic buy | Needham & Company, LLC | |
| 31.07.12 | Strategy (ex MicroStrategy) neutral | UBS AG | |
| 31.07.12 | Fiserv sector perform | RBC Capital Markets | |
| 31.07.12 | Amgen verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 31.07.12 | Veeco Instruments outperform | Exane-BNP Paribas SA | |
| 31.07.12 | Open Text sector outperform | Scotia Capital Markets | |
| 31.07.12 | Apple halten | Independent Research GmbH | |
| 31.07.12 | Anglo American halten | Independent Research GmbH |